Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...

Two tech stocks with more bullish charts that investors may consider as alternatives.

AI can’t be bought off the shelf. Here's how data strategy, pragmatic AI planning and skilled teams form the integrated ...

As AI gains more control over what people see, search and believe, clarity has replaced visibility as the true threshold of ...

Data centers are notably absent from the shopping list for the world’s largest sovereign wealth fund as it unveils a new ...

Norway's $2 trillion wealth fund is being cautious about investing in data centres given sector volatility, its new head of ...

DCMA aims to enhance resilience across the industrial base by expanding the adoption of artificial intelligence and machine ...

With an inquisitive mindset and meticulous process, TalentCompass solves large-scale recruitment puzzles—ushering in a new, ...

Data 360, Salesforce’s unified data foundation that brings together its Data Cloud, Tableau, MuleSoft and Informatica ...

AI infrastructure is booming—learn how energy demands, capex risks, and tech concentration are altering the investment ...

Strategy expands its Bitcoin stash to 660,624 BTC despite declining stock price and slowing DAT inflows, signaling continued ...

The Department of Health and Human Services has set up a plan for AI implementation across the agency that relies on five ...